Publications en collaboration avec des chercheurs de Hospital Universitario 12 de Octubre (23)

2023

  1. A meta-analysis of GFR slope as a surrogate endpoint for kidney failure

    Nature Medicine, Vol. 29, Núm. 7, pp. 1867-1876

  2. Consensus document of the Spanish Group for the Study of the Glomerular Diseases (GLOSEN) for the diagnosis and treatment of lupus nephritis

    Nefrologia, Vol. 43, Núm. 1, pp. 6-47

2022

  1. Acute Treatment Effects on GFR in Randomized Clinical Trials of Kidney Disease Progression

    Journal of the American Society of Nephrology : JASN, Vol. 33, Núm. 2, pp. 291-303

  2. Kidneys also speak Spanish: Initiatives towards standardisation of our nephrology nomenclature

    Nefrologia, Vol. 42, Núm. 3, pp. 223-232

2021

  1. Direct-acting antiviral therapy improves kidney survival in hepatitis C virus-associated cryoglobulinaemia: The RENALCRYOGLOBULINEMIC study

    Clinical Kidney Journal, Vol. 14, Núm. 2, pp. 586-592

  2. Kidneys also speak Spanish

    Nefrologia

  3. Los riñones también hablan español

    Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia

  4. The STARMEN trial indicates that alternating treatment with corticosteroids and cyclophosphamide is superior to sequential treatment with tacrolimus and rituximab in primary membranous nephropathy

    Kidney International, Vol. 99, Núm. 4, pp. 986-998

2020

  1. Risk factors for non-diabetic renal disease in diabetic patients

    Clinical Kidney Journal, Vol. 13, Núm. 3, pp. 380-388

2019

  1. Change in albuminuria as a surrogate endpoint for progression of kidney disease: a meta-analysis of treatment effects in randomised clinical trials

    The Lancet Diabetes and Endocrinology, Vol. 7, Núm. 2, pp. 128-139

  2. IgA nephropathy in elderly patients

    Clinical Journal of the American Society of Nephrology, Vol. 14, Núm. 8, pp. 1183-1192

2018

  1. Aspirin for Primary Prevention of Cardiovascular Disease and Renal Disease Progression in Chronic Kidney Disease Patients: a Multicenter Randomized Clinical Trial (AASER Study)

    Cardiovascular Drugs and Therapy, Vol. 32, Núm. 3, pp. 255-263

  2. Changes in the clinical presentation of immunoglobulin A nephropathy: Data from the Spanish Registry of Glomerulonephritis

    Nephrology Dialysis Transplantation, Vol. 33, Núm. 3, pp. 472-477

2017

  1. Low dose aspirin increases 15-epi-lipoxin A4 levels in diabetic chronic kidney disease patients

    Prostaglandins Leukotrienes and Essential Fatty Acids, Vol. 125, pp. 8-13

2015

  1. Predictors of response and relapse in patients with idiopathic membranous nephropathy treated with tacrolimus

    Nephrology Dialysis Transplantation, Vol. 30, Núm. 3, pp. 467-474

2014

  1. Documento de la sociedad española de nefrología sobre las guías KDIGO para la evaluación y el tratamiento de la enfermedad renal crónica

    Nefrologia, Vol. 34, Núm. 3, pp. 302-316

  2. Microhematuria persistente con proteinuria negativa o de escasa cuantía

    Nefrologia, Vol. 34, Núm. 1, pp. 110-114

2013

  1. 25 (OH) vitamin D levels and renal disease progression in patients with type 2 diabetic nephropathy and blockade of the renin-angiotensin system

    Clinical Journal of the American Society of Nephrology, Vol. 8, Núm. 11, pp. 1870-1876

  2. Effect of dual blockade of the renin-angiotensin system on the progression of type 2 diabetic nephropathy: A randomized trial

    American Journal of Kidney Diseases, Vol. 61, Núm. 2, pp. 211-218

2012

  1. Long-term outcomes of IgA nephropathy presenting with minimal or no proteinuria

    Journal of the American Society of Nephrology, Vol. 23, Núm. 10, pp. 1753-1760